ZNF26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.555600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.246000E-01
Normal-vs-Stage2
4.212000E-01
Normal-vs-Stage3
1.661010E-01
Normal-vs-Stage4
6.059600E-01
Stage1-vs-Stage2
4.196200E-01
Stage1-vs-Stage3
1.696780E-01
Stage1-vs-Stage4
6.508600E-01
Stage2-vs-Stage3
2.777000E-01
Stage2-vs-Stage4
2.373600E-01
Stage3-vs-Stage4
4.352300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.699600E-02
Normal-vs-AfricanAmerican
1.961000E-01
Normal-vs-Asian
4.260000E-02
Caucasian-vs-AfricanAmerican
5.885400E-01
Caucasian-vs-Asian
5.639800E-02
AfricanAmerican-vs-Asian
3.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.305400E-01
Normal-vs-Female
9.529900E-02
Male-vs-Female
9.498200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.957600E-01
Normal-vs-Age(41-60Yrs)
4.480400E-01
Normal-vs-Age(61-80Yrs)
9.070500E-02
Normal-vs-Age(81-100Yrs)
4.475200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.638100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.486840E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.349800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.195400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.421200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.144400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.970600E-01
Normal-vs-Daily Drinker
1.097990E-01
Normal-vs-Weekly Drinker
1.914620E-01
Normal-vs-Occasional Drinker
5.388600E-01
Normal-vs-Social Drinker
4.166400E-01
Non Drinker-vs-Daily Drinker
8.135000E-01
Non Drinker-vs-Weekly Drinker
8.805800E-01
Non Drinker-vs-Occasional Drinker
5.185200E-01
Non Drinker-vs-Social Drinker
7.430000E-01
Daily Drinker-vs-Weekly Drinker
9.626200E-01
Daily Drinker-vs-Occasional Drinker
3.208200E-01
Daily Drinker-vs-Social Drinker
9.543000E-01
Weekly Drinker-vs-Occasional Drinker
4.327200E-01
Weekly Drinker-vs-Social Drinker
9.236000E-01
Occasional Drinker-vs-Social Drinker
2.434000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.587040E-01
Normal-vs-Grade 2
1.586440E-02
Normal-vs-Grade 3
5.306000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.349600E-01
Grade 1-vs-Grade 3
9.596600E-01
Grade 1-vs-Grade 4
1.587040E-01
Grade 2-vs-Grade 3
7.934000E-01
Grade 2-vs-Grade 4
1.586440E-02
Grade 3-vs-Grade 4
5.306000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.022040E-01
Normal-vs-NonDiabetic
7.055900E-02
Diabetic-vs-NonDiabetic
7.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.653400E-01
Normal-vs-NoPancreatitis
4.201800E-01
Pancreatitis-vs-NoPancreatitis
4.937400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.400400E-02
Normal-vs-N1
6.566200E-02
N0-vs-N1
9.321000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.649600E-01
Normal-vs-TP53-NonMutant
2.070000E-01
TP53-Mutant-vs-TP53-NonMutant
8.506200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
